See also this year's filing and all EDGAR filings for this company.
PDF Report 0001736243_2022_Acurx_Pharmaceuticals_Inc.pdf
Logs
warning | Missing logo | subcommand.report | {} |
info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001736243')"} |
Graph
Absolute values for 0001736243, Acurx Pharmaceuticals Inc.
xvar | xval | |
---|---|---|
0 | AssetsCurrent | 0 |
1 | IntangibleAssetsNetIncludingGoodwill | 0 |
2 | PropertyPlantAndEquipmentNet | 0 |
3 | remainder_Assets | 13,254,150 |
4 | LiabilitiesCurrent | 843,909 |
5 | LiabilitiesNoncurrent | 0 |
6 | remainder_Liabilities | 0 |
7 | CostOfGoodsAndServicesSold | 0 |
8 | SellingGeneralAndAdministrativeExpense | 10,784,023 |
9 | ResearchAndDevelopmentExpense | 2,030,177 |
10 | remainder_Expenses | 0 |
11 | remainder_Revenues | 0 |
12 | remainder_NetIncome | 66,503 |
13 | remainder_ComprehensiveNetIncome | 0 |
yvar | yval | |
---|---|---|
0 | Assets | 13,254,150 |
1 | Liabilities | 843,909 |
2 | Expenses | 12,814,200 |
3 | Revenues | 0 |
4 | StockholdersEquity | 12,410,241 |
5 | NetIncome | -12,747,697 |
6 | ComprehensiveNetIncome | -12,747,697 |
7 | BaseVar | 13,489,381 |
8 | EconomicCapitalRatio | 1.22 |